Should Antiarrhythmic Treatment Be Considered Doping in a Shooting Athlete?

Authors

  • Renata Rodrigues Teixeira de Castro Universidade Iguaçu – Faculdade de Medicina – Nova Iguaçu/RJ – Brazil/ Cardiologia do Esporte – Rio de Janeiro/RJ – Brazil. https://orcid.org/0000-0001-5560-693X

Keywords:

Doping, Beta-blocker, Shooting, Pacemaker, Performance

Abstract

Beta-blockers are prohibited for athletes competing in particular sports. This article presents a case of sick sinus syndrome in a master shooting athlete and discuss the potential shooting accuracy enhancement obtained by the treatment beyond beta-blockade.

Downloads

Download data is not yet available.

References

References

WADA. The 2019 Prohibited List International Standard. Montreal, Canada, 2018.

Davis E, Loiacono R, Summers RJ. The rush to adrenaline: drugs in sport acting on the beta-adrenergic system. Br J Pharmacol 2008;154(3):584-97. doi: 10.1038/bjp.2008.164

Fitch K. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes. Clin Med (Lond) 2012;12(3):257-60. doi: 10.7861/clinmedicine.12-3-257

Kruse P, Ladefoged J, Nielsen U, et al. beta-Blockade used in precision sports: effect on pistol shooting performance. J Appl Physiol (1985) 1986;61(2):417-20. doi: 10.1152/jappl.1986.61.2.417

Gallicchio G, Finkenzeller T, Sattlecker G, et al. The influence of physical exercise on the relation between the phase of cardiac cycle and shooting accuracy in biathlon. Eur J Sport Sci 2019;19(5):567-75. doi: 10.1080/17461391.2018.1535626 [published Online First: 2018/10/26]

Downloads

Published

12-03-2021

How to Cite

Castro, R. R. T. de. (2021). Should Antiarrhythmic Treatment Be Considered Doping in a Shooting Athlete?. JOURNAL OF CARDIAC ARRHYTHMIAS, 34(1), 28–31. Retrieved from https://jca.org.br/jca/article/view/3411

Issue

Section

Clinical Arrythmia